Work

CAR-T cells co-targeting BCMA and CD19 in RRMM: Results from the UKMRA Phase 1 MCARTY trial in relapsed refractory multiple myeloma

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-4173

Authors: Lydia Lee, Amatta Mirandari, Aditya Prabu, Eileen Boyle, Catriona Mactier, Juliana Pinto, Mhairi Vaughan, Giulia Agliardi, John Garcia, Evie Lewin, Louisa Green, Eleanor Wooderson, Owen Bain, Yashma Pathak, Bilyana Popova, Beth Jarman, Zainab Kalokoh, Helen Holmes, Cristina Realingo, Simon Thomas, Victoria Spanswick, William Wilson, Christopher Parrish, Maeve O'Reilly, Rakesh Popat, Claire Roddie, Kwee Yong, Martin Pule

Institutions: University College London Hospitals NHS Foundation Trust, University College London, Cancer Research UK, Autolus (United Kingdom), Leeds Teaching Hospitals NHS Trust

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417020436

Cites:

Cited by:

Related to: